A retrospective, observational study of Dupilumab in patients with moderate-to-severe atopic dermatitis
Latest Information Update: 23 Jun 2021
At a glance
- Drugs Dupilumab (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions
- 23 Jun 2021 New trial record
- 05 Jun 2021 Results presented at the 22nd Annual Congress of the European League Against Rheumatism.